Vistagen , a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called ...
Disagree Bot is an AI chatbot built by Brinnae Bent, AI and cybersecurity professor at Duke University and director of Duke's ...
News-Medical.Net on MSN
New method brings hope for personalized treatment of inflammatory bowel disease
Patients with inflammatory bowel disease often have to wait a long time to find the right medicine. But the methods of a ...
Revolutionizing displays, micro-LEDs offer superior brightness and durability, yet manufacturing hurdles must be overcome for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results